Alternatives to indicating roflumilast and the chronic obstructive pulmonary disease classification
Arch Bronconeumol. 2012 Sep;48(9):343.
doi: 10.1016/j.arbres.2012.02.010.
Epub 2012 Apr 21.
[Article in
English,
Spanish]
No abstract available
MeSH terms
-
Aminopyridines / pharmacology
-
Aminopyridines / therapeutic use*
-
Autoimmunity
-
Benzamides / pharmacology
-
Benzamides / therapeutic use*
-
Bronchodilator Agents / pharmacology
-
Bronchodilator Agents / therapeutic use*
-
Cholinergic Antagonists / pharmacology
-
Cholinergic Antagonists / therapeutic use*
-
Comorbidity
-
Cyclopropanes / pharmacology
-
Cyclopropanes / therapeutic use
-
Drug Synergism
-
Humans
-
Immunocompromised Host
-
Infection Control
-
Inflammation
-
Phosphodiesterase 4 Inhibitors / pharmacology
-
Phosphodiesterase 4 Inhibitors / therapeutic use*
-
Pulmonary Disease, Chronic Obstructive / classification*
-
Pulmonary Disease, Chronic Obstructive / drug therapy
-
Pulmonary Disease, Chronic Obstructive / immunology
-
Smoking / adverse effects
-
Smoking / immunology
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Aminopyridines
-
Benzamides
-
Bronchodilator Agents
-
Cholinergic Antagonists
-
Cyclopropanes
-
Phosphodiesterase 4 Inhibitors
-
Tumor Necrosis Factor-alpha
-
Roflumilast